TLMD Stock Overview
SOC Telemed, Inc. provides acute care telemedicine services and technology to hospitals, health systems, physician groups, and government organizations in the United States.
+ 1 more risk
SOC Telemed Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$0.78|
|52 Week High||US$9.48|
|52 Week Low||US$0.78|
|1 Month Change||-48.07%|
|3 Month Change||-60.92%|
|1 Year Change||-89.08%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-92.18%|
Recent News & Updates
SOC Telemed: Virtual Acute Care Niche
SOC Telemed has installed a new management team specifically aiming to reignite growth, but is at least two years away from positive EBITDA. Demographic trends in the United States will exacerbate the problem of matching supply to demand in health care services, and telehealth helps restore some balance. Deep losses in share value over the last year are in line with others in the sector, yet its valuation metrics are beneath its telemedicine and healthcare software services peers.
SOC Telemed: A Pause In Growth
The trends in delivering telehealth continue to expand, with telemedicine encounters remaining at an elevated level relative to pre Covid-19 comparisons. SOC Telemed was a high-growth prospective due to its acquisition of Access Physicians, but the degree of growth has been limited as the delta variant impacts hospitals. The decrease in valuation as a result of its reduced guidance for the rest of 2021 presents a potential entry point for those with a long-term horizon of two-plus years.
|TLMD||US Healthcare||US Market|
Return vs Industry: TLMD underperformed the US Healthcare industry which returned 13.9% over the past year.
Return vs Market: TLMD underperformed the US Market which returned 10.2% over the past year.
|TLMD Average Weekly Movement||17.1%|
|Healthcare Industry Average Movement||8.0%|
|Market Average Movement||6.6%|
|10% most volatile stocks in US Market||15.8%|
|10% least volatile stocks in US Market||2.4%|
Stable Share Price: TLMD is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 17% a week.
Volatility Over Time: TLMD's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
SOC Telemed, Inc. provides acute care telemedicine services and technology to hospitals, health systems, physician groups, and government organizations in the United States. The company’s technology platform, Telemed IQ, provides telemedicine programs. Its telemedicine solutions include teleNeurology, telePulmonology, telePsychiatry, and teleICU.
SOC Telemed Fundamentals Summary
|TLMD fundamental statistics|
Is TLMD overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|TLMD income statement (TTM)|
|Cost of Revenue||US$54.58m|
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
|Earnings per share (EPS)||-1.52|
|Net Profit Margin||-189.93%|
How did TLMD perform over the long term?See historical performance and comparison
Is SOC Telemed undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate TLMD's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate TLMD's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: TLMD is unprofitable, so we can't compare its PE Ratio to the US Healthcare industry average.
PE vs Market: TLMD is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate TLMD's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: TLMD is good value based on its PB Ratio (0.4x) compared to the US Healthcare industry average (2.6x).
How is SOC Telemed forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TLMD is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: TLMD is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: TLMD is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: TLMD's revenue (23.5% per year) is forecast to grow faster than the US market (9.2% per year).
High Growth Revenue: TLMD's revenue (23.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: TLMD is forecast to be unprofitable in 3 years.
How has SOC Telemed performed over the past 5 years?
Last years earnings growth
Earnings and Revenue History
Quality Earnings: TLMD is currently unprofitable.
Growing Profit Margin: TLMD is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if TLMD's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare TLMD's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: TLMD is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (32.5%).
Return on Equity
High ROE: TLMD has a negative Return on Equity (-35.06%), as it is currently unprofitable.
How is SOC Telemed's financial position?
Financial Position Analysis
Short Term Liabilities: TLMD's short term assets ($57.8M) exceed its short term liabilities ($17.4M).
Long Term Liabilities: TLMD's short term assets ($57.8M) do not cover its long term liabilities ($78.0M).
Debt to Equity History and Analysis
Debt Level: TLMD's net debt to equity ratio (20.3%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if TLMD's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TLMD has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: TLMD has sufficient cash runway for 1.2 years if free cash flow continues to reduce at historical rates of 41% each year.
What is SOC Telemed current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate TLMD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate TLMD's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if TLMD's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if TLMD's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of TLMD's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Chris Gallagher (42 yo)
Dr. Christopher M. Gallagher, M.D., FACC, also known as Chris, is a Director at SOC Telemed, Inc. since March 2021 and serves its Chief Executive Officer since September 1, 2021. He serves as Chief Executi...
Experienced Management: TLMD's management team is not considered experienced ( 1 years average tenure), which suggests a new team.
Experienced Board: TLMD's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 31.4%.
SOC Telemed, Inc.'s employee growth, exchange listings and data sources
- Name: SOC Telemed, Inc.
- Ticker: TLMD
- Exchange: NasdaqGS
- Founded: 2004
- Industry: Health Care Services
- Sector: Healthcare
- Implied Market Cap: US$78.858m
- Shares outstanding: 100.89m
- Website: https://www.soctelemed.com
Number of Employees
- SOC Telemed, Inc.
- 1768 Business Center Drive
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/01/19 00:07|
|End of Day Share Price||2022/01/18 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.